Cyclopharm Ltd has released a press release.
Cyclopharm Investor Update
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cyclopharm
- Litigation Update and Receipt of Settlement Payment
- Half Year Accounts
- USFDA Approval Process Update
- Cyclopharm 2023 Half Year Accounts Update - Record Revenues
- Notification of buy-back - CYC
Later from Cyclopharm
- Investor Presentation Correction
- Cyclopharm Receives USFDA Approval for Technegas
- Cyclopharm Signs First USA Contract for Technegas
- Cyclopharm Trading and USA Launch Update
- Cyclopharm to Present at Euroz Hartleys Healthcare Forum
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm